Central Nervous System Infections in Denmark
- Sponsor
- Aalborg University Hospital
- Study ID
- NCT03418441
- Status
- Recruiting
Conditions
- Aseptic Meningitis
- Bacterial Meningitis
- Brain Abscess
- Central Nervous System Infections
- Cerebral Abscess
- Encephalitis
- Lyme Disease
- Meningitis
- Neuroborreliosis
- Neurosyphilis
- Tertiary Syphilis
- Viral Meningitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Community-acquired CNS infections — OTHERProspective observational registration of clinical characteristics and outcome
Study Details
The Danish Study Group of Infections of the Brain is a collaboration between all departments of infectious diseases in Denmark. The investigators aim to monitor epidemiological trends in central nervous system (CNS) infections by a prospective registration of clinical characteristics and outcome of all adult (\>17 years of age) patients with community-acquired CNS infections diagnosed and/or treated at departments of infectious diseases in Denmark since 1st of January 2015.
Key Dates
- Start date
- Jan 1, 2015
- Status verified
- May 2024
- Primary completion
- Jan 1, 2030
- Completion
- Jan 1, 2030
Study Design
- Enrollment
- 1,900 participants (estimated)
Primary Outcome Measure
Incidence [ Time Frame: One year ]
Central Contacts
- Jacob Bodilsen, MD+45 99663920
- Henrik Nielsen, Professor+45 99663920
Related Studies
- A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control PopulationsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Evaluation, Treatment, and Follow-up of Patients With Lyme DiseaseRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruiting · Sanford Health · Sioux Falls, South Dakota
- The ExTINGUISH Trial of Inebilizumab in NMDAR EncephalitisPHASE2 · Recruiting · University of Utah · Birmingham, Alabama